Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Revenue $ 84,025,000 $ 38,268,000 $ 177,731,000 $ 103,100,000
Cost of revenue 64,414,000 30,763,000 141,333,000 86,511,000
Gross profit 19,611,000 7,505,000 36,398,000 16,589,000
Operating expenses:        
Research and development 7,163,000 2,259,000 14,313,000 7,415,000
Sales and marketing 7,272,000 3,423,000 14,791,000 10,155,000
General and administrative 12,631,000 6,441,000 35,597,000 20,737,000
Total operating expenses 27,066,000 12,123,000 64,701,000 38,307,000
Loss from operations (7,455,000) (4,618,000) (28,303,000) (21,718,000)
Other income, net 66,000 38,000 158,000 91,000
Financial expense, net (3,542,000) (468,000) (5,169,000) (1,027,000)
Foreign currency income (loss) (162,000) (548,000) 2,000 (795,000)
Loss before income tax expense (benefit) (11,093,000) (5,596,000) (33,312,000) (23,449,000)
Income tax expense (benefit) 766,000 (263,000) (6,608,000) (1,165,000)
Net loss $ (11,859,000) $ (5,333,000) $ (26,704,000) $ (22,284,000)
Net loss per common share, basic and diluted $ (0.29) $ (0.19) $ (0.75) $ (0.97)
Weighted-average shares used in computing net loss per common share, basic and diluted 41,554,876 28,330,869 35,404,231 22,972,425